Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
168, P. 115721 - 115721
Published: Oct. 16, 2023
Intersected
pathways
between
circadian
timing
system
(CTS),
sleep
regulatory
centers
(SLEEP=Backspace)
and
endocannabinoid
(CB)
towards
cardiometabolic
dysfunctions
disorders
(cardiometabolic
risk).
The
stress
role
is
affected,
both
by
peripheral
(oxidative
signaling
proinflammatory
activation)
central
(autonomic
reaction)
factors
that
are
eventually
related
with
distinct
mediators
as
cyclooxigenase,
nitric
oxide
orexin,
others.
Pharmaceuticals,
Journal Year:
2025,
Volume and Issue:
18(2), P. 148 - 148
Published: Jan. 23, 2025
Background/Objectives:
Current
inflammatory
bowel
disease
(IBD)
treatments
focus
on
symptomatic
relief,
highlighting
the
need
for
innovative
approaches.
Dysregulation
of
cannabinoid
1
(CB1)
receptor,
part
endocannabinoid
system,
is
linked
to
colitis.
While
tetrahydrocannabinol
(THC)
alleviates
colitis
via
CB1
activation,
its
psychotropic
effects
limit
clinical
use.
ZCZ011,
a
CB1R
allosteric
modulator,
and
cannabidiol
(CBD),
non-psychoactive
cannabinoid,
offer
alternatives.
This
study
investigated
combining
sub-therapeutic
THC
doses
with
ZCZ011
or
CBD
in
murine
model
dextran
sodium
sulphate
(DSS)-induced
Methods:
Acute
was
induced
4%
DSS
7
days,
followed
by
3
days
water.
Chronic
modelled
over
24
alternating
concentrations.
The
combination
2.5
mg/kg
20
10
evaluated.
Key
markers
were
assessed
determine
efficacy
safety,
including
activity
index
(DAI),
inflammation,
cytokine
levels,
GLP-1,
organ
health.
Results:
DSS-induced
resulted
increased
DAI
scores,
cytokines,
inflammation
dysregulation
GLP-1
ammonia.
at
significantly
improved
but
ineffective
5
mg/kg.
alone
showed
transient
effects.
However,
either
alleviated
markers,
restored
colon
integrity
reestablished
homeostasis.
also
maintained
favourable
haematological
biochemical
profiles,
notable
reduction
colitis-induced
elevated
ammonia
levels.
Conclusions:
demonstrates
synergistic
potential
low-dose
combined
as
novel,
effective
safer
therapeutic
strategy
ulcerative
Antioxidants,
Journal Year:
2023,
Volume and Issue:
12(8), P. 1490 - 1490
Published: July 26, 2023
Oxidative
stress
(OS),
which
arises
through
an
imbalance
between
the
formation
of
reactive
oxygen
species
(ROS)
and
antioxidant
defenses,
plays
a
key
role
in
pathophysiology
female
infertility,
with
latter
constituting
just
one
number
diseases
linked
to
OS
as
potential
cause.
The
aim
present
article
is
review
literature
regarding
association
infertility.
Among
reproductive
considered
are
endometriosis
polycystic
ovary
syndrome
(PCOS),
while
environmental
pollutants,
lifestyle
variables,
underlying
medical
conditions
possibly
resulting
additionally
examined.
Current
evidence
points
likely
contributing
above
disorders,
amount
damage
done
by
being
influenced
such
variables
duration
severity
exposure
individual’s
age
genetic
predisposition.
Also
discussed
processes
via
may
affect
fertility,
these
including
DNA
mitochondrial
dysfunction.
Finally,
last
section
manuscript
contains
evaluation
treatment
options,
antioxidants
modification,
capable
minimizing
infertile
women.
prime
message
underlined
this
importance
considering
diagnosis
Further
studies
are,
nevertheless
required
identify
best
regimen
its
ideal
duration.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: May 10, 2024
Chronic
inflammation
plays
a
crucial
role
in
the
onset
and
progression
of
pathologies
like
neurodegenerative
cardiovascular
diseases,
diabetes,
cancer,
since
tumor
development
chronic
are
linked,
sharing
common
signaling
pathways.
At
least
20%
breast
colorectal
cancers
associated
with
triggered
by
infections,
irritants,
or
autoimmune
diseases.
Obesity,
inflammation,
cancer
interconnection
underscore
importance
population-based
interventions
maintaining
healthy
body
weight,
to
disrupt
this
axis.
Given
that
dietary
inflammatory
index
is
correlated
an
increased
risk
adopting
anti-inflammatory
diet
supplemented
nutraceuticals
may
be
useful
for
prevention.
Natural
products
their
derivatives
offer
promising
antitumor
activity
favorable
adverse
effect
profiles;
however,
natural
bioactive
drugs
challenging
due
variability
complexity,
requiring
rigorous
research
processes.
It
has
been
shown
combining
products,
such
as
non-steroidal
(NSAIDs),
corticosteroids,
statins,
plant-derived
demonstrate
clinical
utility
accessible
adjuvants
traditional
therapeutic
approaches,
known
safety
profiles.
Pharmacological
approaches
targeting
multiple
proteins
involved
pathogenesis
emerge
particularly
option.
systemic
multifactorial
nature
comprehensive
strategies
essential
long
term
success
therapy.
To
gain
insights
into
carcinogenic
phenomena
discover
diagnostic
clinically
relevant
biomarkers,
pivotal
understand
genetic
variability,
environmental
exposure,
habits,
TME
composition,
establish
based
on
molecular
analysis.
Furthermore,
use
endocannabinoid,
cannabinoid,
prostamide-type
compounds
potential
targets
biomarkers
requires
further
investigation.
This
review
aims
elucidate
specific
etiological
agents
mediators
contributing
persistent
reactions
development.
explores
treatment,
emphasizing
urgent
need
cost-effective
address
cancer-associated
inflammation.
Animals,
Journal Year:
2025,
Volume and Issue:
15(1), P. 101 - 101
Published: Jan. 5, 2025
Twenty-one
adult
crossbreed
dogs
with
chronic
pain
due
to
severe
osteoarthrosis
were
enrolled
in
the
study
(placebo
vs.
treatment
groups).
The
experimental
group
received
dietary
supplement
(Pain
ReliefTM,
Giantec,
Isernia,
Italy)
for
30
days
evaluate
its
effects
on
metabolism
and
relief.
During
trial,
Helsinki
Chronic
Pain
Index
significantly
decreased
(p
<
0.01)
group,
indicating
reduced
improved
quality
of
life.
Additionally,
treated
showed
improvements
oxidative
stress,
demonstrated
by
a
reduction
reactive
oxygen
metabolites,
an
increase
biological
antioxidant
potential.
Interleukins
6
levels
while
interleukins
10
increased,
thus
suggesting
anti-inflammatory
effect
supplement.
Importantly,
no
adverse
observed.
Results
suggest
that
ReliefTM
is
effective
ameliorating
osteoarthritis
dogs,
improving
their
Cells,
Journal Year:
2024,
Volume and Issue:
13(3), P. 268 - 268
Published: Jan. 31, 2024
Research
suggests
the
potential
of
using
cannabinoid-derived
compounds
to
function
as
anticancer
agents
against
melanoma
cells.
Our
recent
study
highlighted
remarkable
in
vitro
effects
PHEC-66,
an
extract
from
Cannabis
sativa,
on
MM418-C1,
MM329,
and
MM96L
cell
lines.
However,
complete
molecular
mechanism
behind
this
action
remains
be
elucidated.
This
aims
unravel
how
PHEC-66
brings
about
its
antiproliferative
impact
these
lines,
utilising
diverse
techniques
such
real-time
polymerase
chain
reaction
(qPCR),
assays
assess
inhibition
CB1
CB2
receptors,
measurement
reactive
oxygen
species
(ROS),
apoptosis
assays,
fluorescence-activated
sorting
(FACS)
for
cycle
analysis.
The
outcomes
obtained
suggest
that
triggers
lines
by
increasing
expression
pro-apoptotic
markers
(BAX
mRNA)
while
concurrently
reducing
anti-apoptotic
(Bcl-2
mRNA).
Additionally,
induces
DNA
fragmentation,
halting
progression
at
G1
checkpoint
substantially
elevating
intracellular
ROS
levels.
These
findings
imply
might
have
adjuvant
therapy
treatment
malignant
melanoma.
it
is
essential
conduct
further
preclinical
investigations
delve
deeper
into
efficacy.
Journal of Agriculture Food Systems and Community Development,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 16
Published: Jan. 1, 2025
Recent
legislative
changes
have
opened
new
avenues
of
hemp
production
for
farmers
seeking
to
diversify
their
operations.
With
the
availability
these
opportunities
comes
need
better
understand
decision
making
processes
growers.
The
purpose
this
study
was
explore
what
motivated
first-year
grow
and
resources
they
utilized
decision-making.
Fifteen
engaged
in
one-on-one
interviews,
which
were
analyzed
using
qualitative
research
methods.
Three
distinct
themes
emerged
that
undergirded
farmer
motivations
hemp:
personal
characteristics,
identified
advantages
as
a
crop,
trialability
compatibility.
Additionally,
four
central
sought
out:
grower
networks,
digital
media,
government-based
resources,
print
media.
findings
align
with
components
Rogers’
Diffusion
Innovation
Theory
recent
related
hemp-based
products.
Based
on
findings,
we
recommend
developing
expanding
educational
those
interested
entering
aid
decision-making
process
assist
them
navigate
entry
into
cultivation.
Nutrition and Dietary Supplements,
Journal Year:
2025,
Volume and Issue:
Volume 17, P. 19 - 28
Published: Feb. 1, 2025
Introduction:
Stress
and
inflammation
in
the
early
stages
of
cognitive
decline
has
spurred
interest
use
antioxidants
as
prophylactic
therapeutic
agents.
Several
studies
have
established
neuroprotective
capacities
a
pomegranate
oil
nano-formulation
(Nano-PSO).
In
parallel,
cannabis-derived
cannabidiol
(CBD)
prevented
social
recognition
deficits
reduced
neuroinflammation
mice.
This
work
assessed
impact
Nano-PSO:CBD
on
memory
learning.
Methods:
A
battery
hemp
extracts
was
screened
for
their
effects
acetylcholine
esterase
inhibition
neuronal
protection
activities.
The
best-performing
extract
in-vitro
assays
nano-formulated
via
self-emulsifying
system
with
PSO
administered
to
aged
mice
MK-801-induced
decline,
which
were
then
subjected
Morris
water
maze
test
Y-maze
test,
respectively.
Results:
Aged
chronically
fed
performed
22–
31%
shorter
escape
latency
(p
≤
0.05),
23%
distance
swam
increased
average
speed
compared
control
Mice
pretreated
prior
MK-801
had
significantly
higher
percentage
entries
into
novel
arm
untreated
controls.
Discussion:
CBD
salutary
effect
memory,
learning
spatial
should
be
further
studied
clinical
context.
Keywords:
cognition,
nanoformulation,
CBD,
seed
oil,
nano-omega
5,
brain
protect,
punicic
acid
Turkish Journal of Biochemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 5, 2025
Abstract
Objectives
Diabetic
cardiomyopathy
(DCM)
is
a
chronic
complication
of
type
2-diabetes
mellitus,
leading
to
heart
failure.
Addressing
DCM
requires
comprehensive
therapeutic
approach.
This
study
examines
the
protective
role
Δ(9)-tetrahydrocannabinol
(THC)
in
by
assessing
its
impact
on
cardiac
function,
inflammation,
oxidative
stress,
and
mitochondrial
health
exploring
involvement
SIRT3/FOXO1
TLR4/NF-κB/NLRP3
signaling
pathways.
Methods
Over
four-week
period,
THC
(1.5
mg/kg,
administered
intraperitoneally)
was
given
type-2
diabetic
Sprague-Dawley
rats.
Cardiac
function
evaluated
using
carotid
catheter
vivo
while
integrity
assessed
through
fluorometric
techniques.
Moreover,
biochemical
biomarkers
protein
expression
key
proteins
were
measured
via
ELISA
immunoblotting.
Results
Compared
untreated
rats,
treatment
showed
pronounced
effects,
improving
reducing
markers
DCM.
It
significantly
lowered
NF-κB,
NLRP3,
IL-1β,
TNF-α
diabetes-induced
stress
heart,
as
evidenced
decreased
malondialdehyde
levels
increased
glutathione
catalase
levels.
also
prevented
membrane
depolarization
reactive
oxygen
species
production
substantially
suppressed
upregulation
TLR4
MyD88
increasing
FOXO1
Inhibition
pathway
3-TYP
reversed
cardioprotective
effects
THC,
negating
NF-κB/NLRP3/IL-1β
without
influencing
TLR4/MyD88.
Conclusions
These
results
underscore
that
offers
significant
protection
against
damage
mitigating
functional
changes
associated
with
DCM,
primarily
modulation
SIRT3/FOXO1/mitochondrial